Joint Care

Fidia has several decades of unparalleled experience developing innovative solutions in key therapeutic areas where hyaluronic acid properties can be effectively, efficiently, and rationally exploited, such as joint care.

Fidia offers an exciting array of therapeutic options for the treatment of osteoarthritis and cartilage damage also subsequent to joint overuse, e.g. sport-related traumatic events.

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Other product websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Russia product portfolio focalizes primarily on joint healthcare.

Fidia Pharma Russia is focused on providing consumers with innovative products that offer quality, safety and performance.